Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Boutemy

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|November 6, 2022
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitisAnaël Dumont, Fabien Labombarda, Sophie Gallou, et al.
Journal of Clinical Medicine|November 25, 2023
Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014-2017 and 2018-2020)Hubert de Boysson, Anael Dumont, Paul Castan, et al.
The Journal of Rheumatology|March 17, 2019
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell ArteritisAnael Dumont, Jean-Jacques Parienti, Claire Delmas, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritisAmandine Lavergne, Anael Dumont, Samuel Deshayes, et al.
Journal of Clinical Medicine|February 25, 2022
Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell ArteritisPaul Castan, Anael Dumont, Samuel Deshayes, et al.
Rheumatology International|October 23, 2025
Impact of gastrointestinal involvement on mortality and malnutrition in systemic sclerosis: an observational cohort of 135 patientsMarie Bader, Achille Aouba, Rémy Morello, et al.
Rheumatology (Oxford, England)|March 18, 2024
Frequency and characteristics of severe relapses in giant cell arteritisNicolas Lozachmeur, Anael Dumont, Samuel Deshayes, et al.
Seminars in Arthritis and Rheumatism|March 21, 2020
Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control studyAnaël Dumont, Anaïs Lecannuet, Jonathan Boutemy, et al.
The American Journal of Medicine|May 3, 2017
Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?Hubert de Boysson, Eric Liozon, Marc Lambert, et al.
European Journal of Internal Medicine|April 5, 2024
Evolution and outcomes of aortic dilations in giant cell arteritisSophie Gallou, Christian Agard, Anael Dumont, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|November 6, 2022
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitisAnaël Dumont, Fabien Labombarda, Sophie Gallou, et al.
Journal of Clinical Medicine|November 25, 2023
Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014-2017 and 2018-2020)Hubert de Boysson, Anael Dumont, Paul Castan, et al.
The Journal of Rheumatology|March 17, 2019
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell ArteritisAnael Dumont, Jean-Jacques Parienti, Claire Delmas, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritisAmandine Lavergne, Anael Dumont, Samuel Deshayes, et al.
Journal of Clinical Medicine|February 25, 2022
Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell ArteritisPaul Castan, Anael Dumont, Samuel Deshayes, et al.
Rheumatology International|October 23, 2025
Impact of gastrointestinal involvement on mortality and malnutrition in systemic sclerosis: an observational cohort of 135 patientsMarie Bader, Achille Aouba, Rémy Morello, et al.
Rheumatology (Oxford, England)|March 18, 2024
Frequency and characteristics of severe relapses in giant cell arteritisNicolas Lozachmeur, Anael Dumont, Samuel Deshayes, et al.
Seminars in Arthritis and Rheumatism|March 21, 2020
Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control studyAnaël Dumont, Anaïs Lecannuet, Jonathan Boutemy, et al.
The American Journal of Medicine|May 3, 2017
Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?Hubert de Boysson, Eric Liozon, Marc Lambert, et al.
European Journal of Internal Medicine|April 5, 2024
Evolution and outcomes of aortic dilations in giant cell arteritisSophie Gallou, Christian Agard, Anael Dumont, et al.
Pageof 4